Effectiveness of cognitive behavioral therapy in the treatment of fibromyalgia syndrome: A meta-analytic literature review

Reumatismo

Volumn 64, Issue 3, 2012, Pages 151-157

  Minelli, A ^a   Vaona, A ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Medico di Medicina Generale   (Italy)

Author keywords

Cognitive behavioral therapy; Fibromyalgia syndrome; Meta analysis; Systematic review

Indexed keywords

ACUPUNCTURE; AMBULATORY CARE; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL EFFECTIVENESS; COGNITIVE DEFECT; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; FIBROMYALGIA; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MUSCLE FATIGUE; MUSCLE STIFFNESS; OUTCOME ASSESSMENT; PATIENT EDUCATION; PHYSICAL DISABILITY; PHYSIOTHERAPY; PUBLICATION; QUALITY OF LIFE; SELF CARE; SLEEP DISORDER; SYSTEMATIC REVIEW; TREATMENT DURATION; ANALGESIA; FATIGUE; TREATMENT OUTCOME;

COGNITIVE THERAPY; FATIGUE; FIBROMYALGIA; HUMANS; PAIN MANAGEMENT; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84865090872     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: 10.4081/reumatismo.2012.151     Document Type: Article

References (18)

1. Ablin J, Neumann L, Buskila D. Pathogenesis of fibromyalgia - a review. Joint Bone Spine. 2008; 75: 273-279.
2. McCarberg BH. Clinical overview of fibromyalgia. Am J Ther 2011. [Epub ahead of print].
3. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010; 62: 600-610.
4. Bradley LA. Pathophysiology of fibromyalgia. Am J Med. 2009; 122: S22-S30.
5. Geiss A, Rohleder N, Anton F. Evidence for an association between an enhanced reactivity of interleukin-6 levels and reduced glucocorticoid sensitivity in patients with fibromyalgia. Psychoneuroendocrinology. 2011. [Epub ahead of print].
6. Gonzalez E, Elorza J, Failde I. Fibromyalgia and psychiatric comorbidity: their effect on the quality of life patients. Actas Esp Psiquiatr. 2010; 38: 295-300.
7. Lewison PM. A behavioural approach to depression. Friedman R, Katz N, New York. 1974.
8. Beck AT. Depression: causes and treatment. University of Pennsylvania Press, Philadelphia. 1967.
9. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009; 62: 1006-1012.
10. Bernardy K, Fuber N, Kollner V, Hauser W. Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome - a systematic review and metaanalysis of randomized controlled trials. J Rheumatol. 2010; 37: 1991-2005.
11. Glombiewski JA, Sawyer AT, Gutermann J, et al. Psychological treatments for fibromyalgia: a meta-analysis. Pain. 2010; 151: 280-295.
12. Sim J, Adams N. Systematic review of randomized controlled trials of nonpharmacological interventions for fibromyalgia. Clin J Pain. 2002; 18: 324-336.
13. Rossy LA, Buckelew SP, Dorr N, et al. A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med. 1999; 21: 180-191.
14. Morris LD, Grimmer-Somers KA, Spottiswoode B, Louw QA. Virtual reality exposure therapy as treatment for pain catastrophizing in fibromyalgia patients: proof-of-concept study (Study Protocol). BMC Musculoskelet Disord. 2011; 12: 85.
15. Edwards RR, Cahalan C, Mensing G, et al. Pain, catastrophizing, and depression in the rheumatic diseases. Nat Rev Rheumatol. 2011; 7: 216-224.
16. Cohen J. Statistical power analysis for the behavioral sciences. Lawrance Erlbaum Associates, Hillsdale, NJ, USA. 1988.
17. Rodero B, Casanueva B, Luciano JV, et al. Relationship between behavioural coping strategies and acceptance in patients with fibromyalgia syndrome: elucidating targets of interventions. BMC Musculoskelet Disord. 2011; 12: 143.
18. Fitzcharles MA, Boulos P. Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. Rheumatology. 2003; 42: 263-267.